Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.41 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.41 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.38 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.37 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2285228 | 0.83 | ALDH1A1 (0.50) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL186269 | 0.83 | ALDH1A1 (0.50) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL8811099 | 0.79 | ESR1 (0.41) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| Cyanide SCHEMBL28871133 | 0.78 | ALDH1A1 (0.47) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL7156428 | 0.77 | CES2 (0.39) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL19062287 | 0.76 | ALDH1A1 (0.46) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL1285613 | 0.74 | ALDH1A1 (0.43) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL186554 | 0.74 | KDM4E (0.44) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL30473828 | 0.74 | ALDH1A1 (0.43) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL28317173 | 0.73 | ALDH1A1 (0.45) | ALDH1A1KDM4EHPGDHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111162313-A | Polymer electrolyte and lithium ion battery | 珠海冠宇电池有限公司 | 2020-05-15 | — | — | CN | claimed |
| EP-0606858-B1 | Liquid crystal compositions and liquid crystal display devices | CHISSO CORP (JP) | 2000-04-26 | — | — | EP | claimed |
| US-5985170-A | OF SUPERTWISTED NEMATIC (STN) MODE, CYANOPHENOL, (TRIFLUOROMETHYL)CYANOPHENOL, AND CYANODIFLUOROPHENOL, CONTROLLING A VOLTAGE HOLDING RATIO | CHISSO CORPORATION (JP) | 1999-11-16 | — | — | US | claimed |
| US-5723065-A | CONDENSED HETEROCYCLE AND AROMATIC AMINE, ALIPHATIC AMINE AND FLUOROCYANOPHENOL | CHISSO CORPORATION (JP) | 1998-03-03 | — | — | US | claimed |
| EP-0606858-A1 | Liquid crystal compositions and liquid crystal display devices | CHISSO CORPORATION (JP) | 1994-07-20 | — | — | EP | claimed |
| JP-9143139-A | — | — | None | — | — | JP | disclosed |
| EP-3750890-B1 | ALKOXYBENZO-FIVE-MEMBERED (SIX-MEMBERED) HETEROCYCLIC AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF | SHIJIAZHUANG YILING PHARMACEUTICAL CO LTD (CN) | 2026-04-01 | — | — | EP | disclosed |
| US-20260062393-A1 | Compounds | CTXT PTY LTD (AU) | 2026-03-05 | — | — | US | disclosed |
| US-20250257076-A1 | SUBSTITUTED PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS cGAS INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2025-08-14 | — | — | US | disclosed |
| US-12365655-B2 | Compounds | CTXT PTY LTD (AU) | 2025-07-22 | — | — | US | disclosed |
| US-20250197388-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE | EMPRESS THERAPEUTICS, INC. | 2025-06-19 | — | — | US | disclosed |
| US-12297209-B2 | Benzodiazepine derivatives as RSV inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| US-5985170-A | OF SUPERTWISTED NEMATIC (STN) MODE, CYANOPHENOL, (TRIFLUOROMETHYL)CYANOPHENOL, AND CYANODIFLUOROPHENOL, CONTROLLING A VOLTAGE HOLDING RATIO | CHISSO CORPORATION (JP) | 1999-11-16 | — | — | US | disclosed |
| WO-1999014187-A1 | BENZAMIDOXIM DERIVATIVES, INTERMEDIATE PRODUCTS AND METHODS FOR PREPARING AND USING THEM AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1999-03-25 | — | — | WO | disclosed |
| US-5723065-A | CONDENSED HETEROCYCLE AND AROMATIC AMINE, ALIPHATIC AMINE AND FLUOROCYANOPHENOL | CHISSO CORPORATION (JP) | 1998-03-03 | — | — | US | disclosed |
| JP-H09143139-A | PRODUCTION OF CYANOFLUOROPHENOL | TOHKEM PROD:KK | 1997-06-03 | — | — | JP | disclosed |
| EP-0606858-A1 | Liquid crystal compositions and liquid crystal display devices | CHISSO CORPORATION (JP) | 1994-07-20 | — | — | EP | disclosed |
| US-5264538-A | Cyclic poly(aryl ether) oligomers | THE DOW CHEMICAL COMPANY (US) | 1993-11-23 | — | — | US | disclosed |
| US-5264520-A | Polymerization of cyclic poly(aryl ether) oligomers | THE DOW CHEMICAL COMPANY (US) | 1993-11-23 | — | — | US | disclosed |
| EP-0413257-A2 | Cyclic poly(aryl ether) oligomers, a process for preparation thereof, and polymerization of cyclic poly (aryl ether) oligomers | THE DOW CHEMICAL COMPANY (US) | 1991-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062393-A1 | Compounds | SCN2B, ABCB11, SCN1B | ALDH1A1 1864/4885KDM4E 800/4885HPGD 4289/4885 |
| US-12297209-B2 | Benzodiazepine derivatives as RSV inhibitors | GABRA5, GABRA1, GABBR2 | ALDH1A1 621/4885KDM4E 1198/4885HPGD 869/4885 |
| US-20250197388-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE | SI, VIP, APC | ALDH1A1 3871/4885KDM4E 1497/4885HPGD 523/4885 |
| US-20250257076-A1 | SUBSTITUTED PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS cGAS INHIBITORS | CGAS, SSB, FPGS | ALDH1A1 1529/4885KDM4E 3122/4885HPGD 247/4885 |
| US-12365655-B2 | Compounds | SLC10A1, ABCB11, PCSK9 | ALDH1A1 982/4885KDM4E 4009/4885HPGD 752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.